Lameness (equine)
Magnetic Resonance Imaging (MRI) produces a 3-dimensional image that allows for exceptional evaluation of soft tissue structures, as well as the detection of boney change and the presence of excessive fluid accumulation associated with inflammation. Like CT, an MRI image may be viewed in various planes of orientation, improving visualization of anatomic structures and any associated pathologic change. MRI is considered the gold standard for diagnosing soft tissue injury within the foot. While it can provide a definitive diagnosis in cases where other imaging modalities have failed, it does have several limitations. Available magnet size restricts imaging to the level of the stifle or elbow, or below. MRI takes a significant amount of time acquire an image, which translates to long anesthesia times and therefore reduces the size of the area that may be imaged in a single session. The area thought to be associated with lameness must be placed in the MRI. MRI is therefore inappropriate for any lameness that can not be localized to a specific region of the limb. Additionally, MRI has limited availability and high cost compared to the other imaging modalities.
TeraView
Due in part to its ability to recognize spectral fingerprints, terahertz pulsed imaging can be applied to provide contrast between different types of soft tissue. Also, it is a sensitive means of detecting the degree of water content and markers of cancer and other diseases. Attempts have been made to apply Terahertz to image cancers like breast, cancer as well as other diseases in medicine, oral health care, and related areas. The company announced it has been cleared by the Medicines and Healthcare products Regulatory Agency (MHRA) to trial "in-vivo" terahertz spectroscopy for bio-medical research. The trials will be held in Guy's Hospital in London and aim to determine if the technology can be applied real-time for accurate removal of cancer tissue.